Home > Rheumatology > ACR 2019 > Spotlight on Rheumatoid Arthritis > Treatment Decisions Should Not Be Guided by Ultrasound Findings

Treatment Decisions Should Not Be Guided by Ultrasound Findings

Presented By
Dr Espen Haavardsholm, Diakonhjemmet Hospital, Oslo, Norway
Conference
ACR 2019
Trial
ARCTIC, TaSER

Common treat-to-target approaches are equally effective compared with additional ultrasound exams for treatment guidance in early rheumatoid arthritis (RA) [1].

In the ARCTIC and the TaSER trials, a trend toward reduced radiographic progression was observed, when ultrasound was added to the assessment, though the ultrasound did not significantly increase benefit vs a treat-to-target strategy. “Patients who seem to have been successfully treated and are free of clinical signs and symptoms of disease may continue to develop permanent structural joint damage. There is a need to find better ways to identify these patients and prevent this development,” Dr Espen Haavardsholm (Diakonhjemmet Hospital, Oslo, Norway), explained the motivation for the presented study.

Data of 230 patients from the ARCTIC study was analysed to evaluate a possible advantage of incorporating ultrasound on the outcome of MRI inflammation or structural damage. Information about MR...



please login to read the entire article:


You need to register to read the entire article, please do so now.





Posted on